Generic placeholder image

Current Respiratory Medicine Reviews

Editor-in-Chief

ISSN (Print): 1573-398X
ISSN (Online): 1875-6387

Research Article

Cost-effectiveness and Accuracy Analysis of Different Screening Strategies for COVID-19

Author(s): Chih-Chien Cheng, Chia-Chen Liu, Hao-Yu Liu, Yi-Chang Chou, Yung-Feng Yen, Yi-Chun Chiu, Li-Yun Fann and Chuan-Yi Chou*

Volume 21, Issue 3, 2025

Published on: 12 September, 2024

Page: [202 - 207] Pages: 6

DOI: 10.2174/011573398X296534240828111955

Price: $65

Abstract

Background: Coronavirus disease 2019 (COVID-19) is mainly confirmed through reverse transcription polymerase chain reaction (RT-PCR), which is both expensive and time-consuming and requires specific equipment. Thus, demand for rapid diagnostic methods, such as rapid antigen detection (RAD) tests, has emerged. Here, we assessed the efficiency and reliability of RAD for early diagnosis of COVID-19.

Methods: We performed a retrospective study based on systemic COVID-19 screening and diagnosis using RAD and RT-PCR at Taipei City Hospital during the first COVID-19 outbreak week in Taiwan (28 May-6 June 2021). We postulated five strategies for COVID-19 screening in the general population: one RAD test, one RT-PCR test, one RAD test (negative) followed by one RT-PCR, one RAD test (positive) followed by one RT-PCR test, and two RAD tests and calculated their cost and accuracy. We also conducted a cost-effectiveness analysis to identify the most economically efficient strategy for COVID-19 diagnosis. This study included 6368 cases in total.

Results: Although RAD exhibited low sensitivity (mean 66%), other values were acceptable: mean specificity, positive predictive value, negative predictive value, and accuracy were 99%, 82.8%, 97.5%, and 94.2%, respectively. RAD was the most cost-effective method. Additionally, it may be an effective diagnostic strategy in the later stages of the epidemic, warranting further research.

Conclusion: Although RT-PCR remains the standard method for diagnosing COVID-19, RAD is faster and a more cost-effective, convenient, and globally available method, allowing for early detection of SARS-CoV-2.

Keywords: COVID-19, SARS-CoV-2, reverse transcription polymerase chain reaction, rapid antigen detection, cost-effectiveness, sensitivity.

Graphical Abstract
[1]
WHO Coronavirus (COVID-19). Dashboard 2023. https://covid19.who.int/
[2]
Cheng CC, Liu CC, Yen JC, et al. Systematic screening for SARS-CoV-2 to detect asymptomatic infections: An epitome of Taiwan’s outbreak. Can J Infect Dis Med Microbiol 2022; 2022: 1-7.
[http://dx.doi.org/10.1155/2022/6441339] [PMID: 35178135]
[3]
Taiwan centers for disease control. Available from: https://www.cdc.gov.tw/
[4]
Yamayoshi S, Sakai-Tagawa Y, Koga M, et al. Comparison of rapid antigen tests for COVID-19. Viruses 2020; 12(12): 1420.
[http://dx.doi.org/10.3390/v12121420] [PMID: 33322035]
[5]
Cheng CC, Liu CC, Chiu TF, Shiou-Sheng Chen S. Evaluation of a rapid antigen test for the diagnosis of SARS-CoV-2 during the COVID-19 pandemic. Inquiry 2022; 59
[http://dx.doi.org/10.1177/00469580221105354] [PMID: 35658567]
[6]
Jian MJ, Perng CL, Chung HY, et al. Clinical assessment of SARS-CoV-2 antigen rapid detection compared with RT-PCR assay for emerging variants at a high-throughput community testing site in Taiwan. Int J Infect Dis 2022; 115: 30-4.
[http://dx.doi.org/10.1016/j.ijid.2021.11.034] [PMID: 34843956]
[7]
Maniscalco M, Ambrosino P, Ciullo A, et al. A rapid antigen detection test to diagnose SARS-CoV-2 infection using exhaled breath condensate by a modified Inflammacheck® device. Sensors 2021; 21(17): 5710.
[http://dx.doi.org/10.3390/s21175710] [PMID: 34502603]
[8]
Dinnes J, Sharma P, Berhane S, et al. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection. Cochrane Libr 2022; 2022(7): CD013705.
[http://dx.doi.org/10.1002/14651858.CD013705.pub3] [PMID: 35866452]
[9]
Lee J, Song JU, Shim SR. Comparing the diagnostic accuracy of rapid antigen detection tests to real time polymerase chain reaction in the diagnosis of SARS-CoV-2 infection: A systematic review and meta-analysis. J Clin Virol 2021; 144: 104985.
[http://dx.doi.org/10.1016/j.jcv.2021.104985] [PMID: 34560340]
[10]
Salvetti S, Lavinia F, Rosi N, et al. A rapid and cost-effective diagnostic algorithm for the detection of SARS-CoV-2 infection in the emergency area by combining highly sensitive antigenic test and RT-PCR. Diagn Microbiol Infect Dis 2022; 103(4): 115727.
[http://dx.doi.org/10.1016/j.diagmicrobio.2022.115727] [PMID: 35700658]
[11]
Vander Schaaf NA, Fund AJ, Munnich BV, et al. Routine, cost-effective SARS-CoV-2 surveillance testing using pooled saliva limits viral spread on a residential college campus. Microbiol Spectr 2021; 9(2): e01089-21.
[http://dx.doi.org/10.1128/Spectrum.01089-21] [PMID: 34643445]
[12]
Fenollar F, Bouam A, Ballouche M, et al. Evaluation of the panbio COVID-19 rapid antigen detection test device for the screening of patients with COVID-19. J Clin Microbiol 2021; 59(2): e02589-20.
[http://dx.doi.org/10.1128/JCM.02589-20] [PMID: 33139420]
[13]
Elli S, Blasi F, Brignolo B, et al. Diagnostic accuracy of rapid antigen test for COVID-19 in an emergency department. Diagn Microbiol Infect Dis 2022; 102(4): 115635.
[http://dx.doi.org/10.1016/j.diagmicrobio.2022.115635] [PMID: 35216863]
[14]
Cattelan AM, Sasset L, Zabeo F, et al. Rapid antigen test LumiraDxTM vs. real time polymerase chain reaction for the diagnosis of SARS-CoV-2 infection: A retrospective cohort study. Int J Environ Res Public Health 2022; 19(7): 3826.
[http://dx.doi.org/10.3390/ijerph19073826] [PMID: 35409513]
[15]
Wertenauer C, Pfeifer C, Roskos M, März W. Rapid antigen tests for SARS-CoV-2—A synopsis of the medical evidence. Diagn Microbiol Infect Dis 2023; 107(2): 116027.
[http://dx.doi.org/10.1016/j.diagmicrobio.2023.116027] [PMID: 37516068]
[16]
World Health Organization Use of SARS-CoV-2 antigen-detection rapid diagnostic tests for COVID-19 self-testing 2022. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Ag-RDTs-Self_testing-2022.1
[17]
Cedro VQM, de Lima Gomes S, Simões ACCD, et al. Cost-effectiveness analysis of COVID-19 tests in the unified health system. Cost Eff Resour Alloc 2023; 21(1): 64.
[http://dx.doi.org/10.1186/s12962-023-00469-1] [PMID: 37705076]
[18]
Rahmanzadeh F, Malekpour N, Faramarzi A, Yusefzadeh H. Cost-effectiveness analysis of diagnostic strategies for COVID-19 in Iran. BMC Health Serv Res 2023; 23(1): 861.
[http://dx.doi.org/10.1186/s12913-023-09868-9] [PMID: 37580701]

Rights & Permissions Print Cite
© 2026 Bentham Science Publishers | Privacy Policy